Abstract
The field of medicine and pharmaceuticals has experienced revolutionary changes due to the development of nanotechnology. Materials or their constructions with size less than 100 nm along at least one dimension are termed as nanoparticulates. Nanoparticulates possess a greater surface area to volume ratio in comparison with bulk materials with the same composition to provide them enhanced selective therapeutic activity and are useful in the pharmaceutical field besides many other applications. Novel formulations of nanomaterials are being developed for drug encapsulation, targeted drug delivery systems (TDDs), and diagnostic purposes. Examples include polymeric nanoparticles in the form of nanospheres and nanocapsules; colloidal drug carriers such as micelles, dendrimers; phospholipid-based drug delivery systems, e.g., liposomes, phytosomes, ethosomes, etc.; solid-lipid nanoparticles (SLNs); niosomes; biphasic systems such as nanoemulsions and nanocomposite hydrogels; quantum dots; carbon nanotubes (CNTs), etc. TDDs involve direct application of drugs to the desired individual tissues with minimal damage to non-target tissues and organs resulting in the lesser requirement of drugs with enhanced biological response and protection from physical and chemical degradation. Nonmaterials not only increase the therapeutic value of drugs but also reduce their toxicological effects compared to conventional therapies. Nanomaterials, especially lipidic systems have excellent biotransformation response besides enhancing solubility and bioavailability of drugs. Nanoparticle-based dosage forms utilizing enhanced permeation and retention (EPR) effect through the biological barriers help in improving the pharmacokinetic profile and pharmacodynamic activity of the drugs. This chapter is devoted to various nanoparticulates (synthetic, semi-synthetic, and natural) having existing and potential applications in the pharmaceutical field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Poole CP Jr, Frank J (2003) Owens; introduction to nanotechnology. Wiley Interscience, New Jersey, pp 1–388
Singh S (2017) Nanoscience and nanotechnology, 1st edn, pp 1–352. Pragati Prakashan, Meerut, India
Smijs TGM et al (2011) Nanotechnol Sci Appl 4(1):95–112
Franci G et al (2015) Molecules 20:8856–8874
Gupta M, Sharma V (2011) Res J Chem Sci 1(2):135–138
Wu L, San L (2011) J. Nanomater. https://doi.org/10.1155/2011/530874
Brahamdutt et al (2018) Int J Res Dev Pharm Life Sci. https://dx.doi.org/10.21276/IJRDPL.2278-0238.2018.7(3).2969-2981
Sharma D, Hussain CM (2018) Arab J Chem. https://doi.org/10.1016/j.arabjc,2018.11.007
Liu J et al (2014) Biotechnol Adv 32(4):693–710
Chen S et al (2013) Eur J Nanomed 5(2):61–79
Chatterjee DK, Yong Z (2008) Nanomedicine 3:373–382
Lantsova AV et al (2020) Bull Exp Biol Med 168(3):361–365
Ho YP, Leong KW (2010) Nanoscale 2:60–68
Chang S et al (2009) Toxicol Lett 188:104–111
Akbarzadeh et al (2018) Exp Oncol 40(3):178–183
Misra et al (2010) Drug Discov Today 15:842–850
Bechet D et al (2008) Trends Biotechnol 26:612–621
Singh S (2019) Nanomaterials and applications, 1st edn. Pragati Prakashan, Meerut, India
Olivo M et al (2010) Pharmaceuticals 3:1507–1529
Ghosh S et al (2009) ACS Nano 3:2667–2673
Huang X et al (2006) J Am Chem Soc 128:2115–2120
Khandhar AP et al (2011) J Appl Phys 310:109
Liu X et al (2012) J Mater Chem 22:8235–8244
Wang J et al (2011) Ultrason Sonochem 18:177–183
Hernandez R et al (2004) J Am Chem Soc 126:33370–33371
Kim K et al (2010) J Control Release 146:219–227
https://commons.wikimedia.org/wiki/File:Micelle_scheme-en.svg. accessed on 25 June 2020
Tiwari Gaurav et al (2012) Int J Pharm Investig 2(1):2–11
Soleymani Abyaneh H. et al.; Acta Biomater., Vol 24, (2015), pp 127–139: https://doi.org/10.1016/j.actbio.2015.06.017
Owen SC et al (2012) Nano Today 7:53–65
Nishi H (1997) J Chromatogr A 780(1–2):243–264
Kuno M (2004) Introduction to nanoscience and nanotechnology: a workbook, pp 185–186
Li Y et al (2018) J Drug Target 26(9):753–765
Amjad MW et al (2017) Progress in polymer science, vol 64, pp 154–181
Taghavi N et al (2013) Hacettepe J Biol Chem 41(3):289–299
Shi X et al (2018) Pharmaceutics 10(3):162
Lyu Z et al (2019) Mater Today Chem 13:34–38
Zhu J, Shi X (2013) J Mater Chem 1:4199–4211
Abbasi E et al (2014) Nanoscale Res Lett 9:247
Mehra NK et al (2015) Drug Discovery Today 20:750–759
Christoforidis JB et al (2012) Hindawi Publishing Corporation. https://doi.org/10.1155/2012/126463
Mady M et al (2009) Biophys Structure Mechanism 38(8):1127–1133
Zhou F et al (2018) Food Hydrocolloids 83. https://doi.org/10.1016/j.foodhyd.2018.04.040
Chen et al (2016) Colloids Surfaces B Biointerfaces 143:455–462
Wei X-Q et al (2019) ACS omega. https://dx.doi.org/10.1021/acsomega.9603293
Han et al (2016) Int J Nanomed 11:1413–1425
Kibria G et al (2011) J Controlled Release 153:141–148
Markov OO et al (2012) J Controlled Release 160:200–210
Yuan L et al (2013) Int J Pharm 454:82–89
Miatmoko A et al (2019) European Pharmaceutical J
Alving CR et al (2020) Expert Rev Vaccines 19(3):279–292
Nagavarma BVN et al (2012) Asian J pharm Clin Res 5(3):16–20
Xie Y et al (2020) Journal of American Chemical Society; Vol 142 (3), (2020), pp 1475–1481
Wei L et al (2015) Drug Discovery Today 20(5):595–596
Kaur H et al (2011) Int J Biol Macromol 1:833–837
Szczech M, Szczepanowicz K (2020) Nanomaterials 10(3):496
Kakadia PG, Conway BR (2014) Am J Pharmacol Sci 2(5A):1–7
Almeida AJ et al (2007) Adv Drug Deliv Rev 59(6):478–490
Mukherjee et al (2009) Indian J Pharm Sci 71(4):349–358
Yadav P et al (2014) Int J Pharm Sci Res 5(4):1152–1162
Vighi E et al (2010) Int J Pharm 389(1–2):254–261
Vijayanand P et al (2018) J Drug Deliv 2018. https://doi.org/10.1155/2018/2908626
Arif et al Mater Sci Eng. https://doi.org/10.1016/j.msec.2017.02.114
Krishnatreyya H et al (2019) Indian J Pharm Educ Res 53(2s):82–92
Müller RH, Mäder K, Gohla Sven (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur J Pharm Biopharm 50(1):161–177
Sahinwala A et al (2002) J Pharm Sci 5(3):220–225
Gharbavi M et al (2018) Adv Pharm Sci. https://doi.org/10.1155/2018/6847971
Uchegbu L (2014) Synthetic surfactant vesicles: niosomes and other non-phospholilid vesicular systems. CRC Press, Boca Raton, USA
Mohite M, Kumbhar T (2019) World J Pharm Res 8(6):1303–1318
Chatterjee S, Chi-leung Hui P (2018) Stimuli-responsive hydrogels: an interdisciplinary overview. Hydrogels Smart Mater Biomed Appl. https://doi.org/10.5772/intechopen.80536
Bahram M et al (2016) An introduction to hydrogels and some recent applications. https://doi.org/10.5772/64301
Vashist A et al (2018) Gels 4(75):1–15. https://doi.org/10.3390/gels4030075
Patel VR, Amiji MM (1996) J Pharm Res 13:588–599
Torres-Martinez A et al (2019) Langmuir 35:13375–13381
Wahab Amjad M, Ghafoor Raja MA (2019) J Pharm Res Int 27(11):1–7
Jaiswal M et al (2015) 3 Biotech 5:123–127. https://doi.org/10.1007/s13205-014-0214-0
Chen L et al Int J Pharm https://doi.org/10.1016/j.ijpharm.2017.10.005
Huihui B et al (2014) Int J Pharm 471:206–213
Gaba B et al BioMed Res Int 2019. https://doi.org/10.1155/2019/2382563
Sanchez-Lopez E et al (2019) Nanomaterials (Basel) 9(6):821. https://doi.org/10.3390/nano9060821
Patel VR, Agarwal YK (2011) J Adv Pharm Technol Res 2(2):81–87. https://doi.org/10.4103/2231-4040.82950
Goel S et al (2019) Recent Pat Drug Deliv Formul 13(2):91–104. https://doi.org/10.2174/187221131366619061415161
Jacob S et al (2020) Biomater Res 24(3). https://doi.org/10.1186/s40824-020-0184-8
Boedeker BH et al (1994) J Clin Pharmacol 34:699
Karan SM et al (1996) Anesth Analg 82:796
Ward G et al (1993) J Parenter Sci Technol 47:161
Ibrahim MA et al (2019) Saudi Pharm J 27(1):49–55
Conflicts of Interest
The authors declare that there are no conflicts of interest involved in this work.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Singh, S., Tiwari, S.B., Tyagi, S. (2021). Nanomaterials for Pharmaceutical Applications. In: Khan, Z.H. (eds) Emerging Trends in Nanotechnology. Springer, Singapore. https://doi.org/10.1007/978-981-15-9904-0_8
Download citation
DOI: https://doi.org/10.1007/978-981-15-9904-0_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-9903-3
Online ISBN: 978-981-15-9904-0
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)